Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;3(2):10-23.
doi: 10.1080/21507716.2011.653472.

Developing a Model of the Benefits and Burdens of Research Participation in Cancer Clinical Trials

Connie M Ulrich  1 , Kathleen A Knafl  2 , Sarah J Ratcliffe  3 , Therese S Richmond  1 , Christine Grady  4 , Claiborne Miller-Davis  4 , Gwenyth R Wallen  4
Affiliations

Developing a Model of the Benefits and Burdens of Research Participation in Cancer Clinical Trials

Connie M Ulrich et al. AJOB Prim Res. 2012.

Abstract

Background: Recruiting and retaining human participants in cancer clinical trials is challenging for many investigators. Although we expect participants to identify and weigh the benefits and burdens of research participation for themselves, it is not clear what burdens adult cancer participants perceive in relation to benefits. We identify key attributes and develop an initial conceptual framework of benefit and burden based on interviews with individuals enrolled in cancer clinical research.

Methods: Semistructured interviews were conducted with a purposive sample of 32 patients enrolled in cancer clinical trials at a large northeastern cancer center. Krueger's guidelines for qualitative methodology were followed.

Results: Respondents reported a range of benefits and burdens associated with research participation. Benefits such as access to needed medications that subjects otherwise might not be able to afford, early detection and monitoring of the disease, potential for remission or cure, and the ability to take control of their lives through actively participating in the trial were identified. Burdens included the potentiality of side effects, worry and fear of the unknown, loss of job support, and financial concerns.

Conclusions: Both benefit and burden influence research participation, including recruitment and retention in clinical trials. Dimensions of benefit and burden include physical, psychological, economic, familial, and social. Understanding the benefit-burden balance involved in the voluntary consent of human subjects is a fundamental tenet of research and important to ensure that subjects have made an informed decision regarding their decision to participate in clinical research.

Keywords: benefits; burdens; cancer; clinical trials; qualitative methods.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A model outlining the benefits and burdens of research participation. (Further testing is needed to determine the relationships among the dimensions.)
See this image and copyright information in PMC

References

    1. Advani AS, Atkeson B, Brown CL, et al. Barriers to the participation of African-American patients with cancer in clinical trials. Cancer. 2003;97:1499–1506. doi: 10.1002/cncr.11213. - PubMed
    1. Appelbaum PS, Roth LH, Lidz C. The therapeutic misconception: Informed consent in psychiatric research. International Journal of Law and Psychiatry. 1982;5:319–29. - PubMed
    1. Appelbaum PS, Roth LH, Lidz C, Benson P, Winslade W. False hopes and bestdata: Consent to research and the therapeutic misconception. Hastings Center Report. 1987;17:20–4. - PubMed
    1. Balboni T, Vanderwerken L, Block S, et al. Religiousness and spiritual support among advanced cancer patients and associat7ion with end-of-life treatment preferences and quality of life. Journal of Clinical Oncology. 2007;25:467–468. - PMC - PubMed
    1. Bradburn N. Respondent burden. Presented at Health survey research methods: Second biennial conference (Williamsburg, VA); Washington, DC. 1977.

LinkOut - more resources